Search Results

At Teva we believe that everyone should have access to safe quality medicine that helps manage disease fights infection or simply improves overall health

Manufacturing Science Technology MS T is responsible for technology and manufacturing process support for every product we make in Teva We spoke to the female led global team to learn more

Explore top tier in licensing opportunities with Medis a trusted name in the pharmaceutical industry since 1985 Offering a diverse portfolio of 185 generic pharmaceutical products across various therapeutic areas Medis is backed by Teva Pharmaceuticals to ensure technical excellence and regulatory compliance Discover how our dedicated teams including business development and customer experience managers can support your in licensing needs and streamline the product lifecycle process

Teva is a leading global provider of quality affordable medicines for nearly every health condition and every day 200 million people around the world take a Teva product Meet the people and hear the stories behind those medicines

Join Jessica Payne device engineer and member of the Combination Products and Devices team at the Teva Research Development lab in West Chester US on a project focused assignment at Teva sites in Ireland and Croatia

Cory Wohlbach is responsible for steering Teva s new biosimilar products through the regulatory approval process He explains what biosimilars are how they have the potential to reduce costs for patients and how patient safety is always a top priority

Ivana Šoljić Jerbić lead scientist in the development of complex sterile medicines at Teva Croatia talks about her work collaborating with people all over the world Read more

Meet Paula who runs Teva s dedicated clinical trial facility in Florida A lot of work goes in to researching and testing drugs to make sure patients receive safe quality medicine Read Paula s story and see how it s done

From medicine shortages to over regulation and anomalies in global approvals for biosimilars Richard Daniell Teva s EVP Europe Commercial Global Generics Franchise outlines the key trends in the generic medicines field

Teva s ESG strategy guides how we advance health and equity minimize our impact on the planet and dedicate ourselves to quality ethics and transparency It drives us to be responsible in all we do take a look at how this came to life in 2021

We explain why generic medicines are an essential part of modern healthcare and look at the research development processes and logistical challenges involved in creating them

Órla Barron and Peter Gargya long time Teva Pharmacovigilance employees share their thoughts on successfully redesigning complex processes and the future of patient safety

Teva s Chief Medical Officer Eric Hughes outlines the key efficiencies to be gained from artificial intelligence AI

Read the latest and past featured stories from Teva Pharmaceuticals and discover the newest developments of the health section